Literature DB >> 19919181

Biochemical characterization of human Ecdysoneless reveals a role in transcriptional regulation.

Jun Hyun Kim1, Channabasavaiah Basavaraju Gurumurthy, Hamid Band, Vimla Band.   

Abstract

Ecdysoneless (Ecd) is an evolutionarily conserved protein and its function is essential for embryonic development in Drosophila and cell growth in yeast. However, its function has remained unknown until recently. Studies in yeast suggested a potential role of Ecd in transcription; however, Ecd lacks a DNA-binding domain. Using a GAL4-luciferase reporter assay and a GAL4 DNA-binding domain fusion with Ecd or its mutants, we present evidence that human Ecd has a transactivation activity in its C-terminal region. Importantly, further analyses using point mutants showed that a single amino acid change at either Asp-484 or Leu-489 essentially completely abolishes the transactivation activity of Ecd. We further demonstrate that Ecd interacts with p300, a histone acetyltransferase, and coexpression of Ecd with p300 enhances the Ecd-mediated transactivation activity. Ecd localizes to both nucleus and cytoplasm and shuttles between the nucleus and cytoplasm; however, it exhibits strong nuclear export. Based on previous yeast studies and evidence provided here, we suggest that Ecd functions as a transcriptional regulator. Our results indicate an important function of human Ecd and provide a basis to explore the transcriptional partners of Ecd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19919181      PMCID: PMC3902786          DOI: 10.1515/BC.2010.004

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  21 in total

Review 1.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

2.  NESbase version 1.0: a database of nuclear export signals.

Authors:  Tanja la Cour; Ramneek Gupta; Kristoffer Rapacki; Karen Skriver; Flemming M Poulsen; Søren Brunak
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.

Authors:  H J Park; Z Wang; R H Costa; A Tyner; L F Lau; P Raychaudhuri
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

4.  An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.

Authors:  J Dennig; M Beato; G Suske
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

5.  A new class of yeast transcriptional activators.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

6.  Repression of a herpes simplex virus immediate-early promoter by the Oct-2 transcription factor is dependent on an inhibitory region at the N terminus of the protein.

Authors:  K A Lillycrop; S J Dawson; J K Estridge; T Gerster; P Matthias; D S Latchman
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 7.  Acetylation of general transcription factors by histone acetyltransferases.

Authors:  A Imhof; X J Yang; V V Ogryzko; Y Nakatani; A P Wolffe; H Ge
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

8.  The role of Gcr1p in the transcriptional activation of glycolytic genes in yeast Saccharomyces cerevisiae.

Authors:  H Uemura; M Koshio; Y Inoue; M C Lopez; H V Baker
Journal:  Genetics       Date:  1997-10       Impact factor: 4.562

9.  Specialized Rap1p/Gcr1p transcriptional activation through Gcr1p DNA contacts requires Gcr2p, as does hyperphosphorylation of Gcr1p.

Authors:  X Zeng; S J Deminoff; G M Santangelo
Journal:  Genetics       Date:  1997-10       Impact factor: 4.562

10.  A human gene, hSGT1, can substitute for GCR2, which encodes a general regulatory factor of glycolytic gene expression in Saccharomyces cerevisiae.

Authors:  T Sato; Y Jigami; T Suzuki; H Uemura
Journal:  Mol Gen Genet       Date:  1999-01
View more
  8 in total

1.  Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis.

Authors:  Parama Dey; Satyanarayana Rachagani; Subhankar Chakraborty; Pankaj K Singh; Xiangshan Zhao; Channabasavaiah Basavaraju Gurumurthy; Judy M Anderson; Subodh Lele; Michael A Hollingsworth; Vimla Band; Surinder K Batra
Journal:  Clin Cancer Res       Date:  2012-09-12       Impact factor: 12.531

2.  A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP Complex Component RUVBL1 Is Required for the Functional Role of ECD in Cell Cycle Progression.

Authors:  Riyaz A Mir; Aditya Bele; Sameer Mirza; Shashank Srivastava; Appolinaire A Olou; Shalis A Ammons; Jun Hyun Kim; Channabasavaiah B Gurumurthy; Fang Qiu; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

Review 3.  Breast cancer subtypes: two decades of journey from cell culture to patients.

Authors:  Xiangshan Zhao; Channabasavaiah Basavaraju Gurumurthy; Gautam Malhotra; Sameer Mirza; Shakur Mohibi; Aditya Bele; Meghan G Quinn; Hamid Band; Vimla Band
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis.

Authors:  Sameer Mirza; Achyuth Kalluchi; Mohsin Raza; Irfana Saleem; Bhopal Mohapatra; Dhananjaya Pal; Michel M Ouellette; Fang Qiu; Lulu Yu; Alexei Lobanov; Zhi-Ming Zheng; Ying Zhang; Mansour A Alsaleem; Emad A Rakha; Hamid Band; M Jordan Rowley; Vimla Band
Journal:  Mol Cancer Res       Date:  2021-10-20       Impact factor: 6.333

5.  The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export.

Authors:  Irfana Saleem; Sameer Mirza; Aniruddha Sarkar; Mohsin Raza; Bhopal Mohapatra; Insha Mushtaq; Jun Hyun Kim; Nitish K Mishra; Mansour A Alsaleem; Emad A Rakha; Fang Qiu; Chittibabu Guda; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2021-06-23       Impact factor: 4.272

6.  Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.

Authors:  Xiangshan Zhao; Sameer Mirza; Alaa Alshareeda; Ying Zhang; Channabasavaiah Basavaraju Gurumurthy; Aditya Bele; Jun Hyun Kim; Shakur Mohibi; Monica Goswami; Subodh M Lele; William West; Fang Qiu; Ian O Ellis; Emad A Rakha; Andrew R Green; Hamid Band; Vimla Band
Journal:  Breast Cancer Res Treat       Date:  2012-01-22       Impact factor: 4.872

7.  ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation.

Authors:  Song-Hui Xu; Song Zhu; Yanjie Wang; Jin-Zhou Huang; Min Chen; Qing-Xia Wu; Yu-Tian He; Guang-Rong Yan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

8.  Unexpected role of the steroid-deficiency protein ecdysoneless in pre-mRNA splicing.

Authors:  Ann-Katrin Claudius; Patrizia Romani; Tobias Lamkemeyer; Marek Jindra; Mirka Uhlirova
Journal:  PLoS Genet       Date:  2014-04-10       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.